Impact of BRAF mutation in patients with brain metastasis from melanoma.

被引：0
|
作者：
Venur, Vyshak Alva
Kotecha, Rupesh
Chen, Zhijian
Chao, Samuel T.
Elson, Paul
Suh, John H.
Ahluwalia, Manmeet Singh
机构：
[1] Cleveland Clin, Fairview Hosp, Cleveland, OH 44106 USA
[2] Cleveland Clin Fdn, Dept Radiat Oncol, Cleveland, OH 44195 USA
[3] Cleveland Clin, Cleveland Hts, OH USA
[4] Cleveland Clin, University Hts, OH USA
[5] Cleveland Clin, Cleveland, OH 44106 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e13016
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Impact of BRAF mutation and BRAF inhibition on melanoma brain metastases
    Gummadi, Tulasi
    Zhang, Ben Y.
    Valpione, Sara
    Kim, Chul
    Kottschade, Lisa A.
    Mittapalli, Rajendar K.
    Chiarion-Sileni, Vanna
    Pigozzo, Jacopo
    Elmquist, William F.
    Dudek, Arkadiusz Z.
    [J]. MELANOMA RESEARCH, 2015, 25 (01) : 75 - 79
  • [2] Impact of BRAF mutation and effectiveness of BRAF inhibitor on the brain metastases in patients with metastatic melanoma
    Gummadi, Tulasi
    Dronca, Roxana Stefania
    Kim, Chul
    Kottschade, Lisa A.
    Mittapalli, Rajendar K.
    Elmquist, William F.
    Dudek, Arkadiusz
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [3] BRAF mutation as a pejorative marker in metastatic melanoma.
    Brissy, Sophie
    Gaudy-Marqueste, Caroline
    Mallet, Stephanie
    Monestier, Sandrine
    Hesse, Sylvie
    Koeppel, Marie-Christine
    Rojat-Habib, Marie-Christine
    Nanni, Isabelle
    Loundou, Anderson
    Ouafik, L'houcine
    Bonnet, Nathalie
    Richard, Marie-Aleth
    Grob, Jean Jacques
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [4] Prognostic role of BRAF mutation in malignant cutaneous melanoma.
    Sehdev, Amikar
    Hayden, Ross
    Kuhar, Mathew Joseph
    Cheng, Liang
    Warren, Simon John
    Mark, Lawrence Aaron
    Wooden, William Arthur
    Schwartzentruber, Douglas Jay
    Logan, Theodore F.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [5] Efficacy of immune checkpoint inhibitors in patients with brain metastasis from NSCLC, RCC, and melanoma.
    Lauko, Adam
    Thapa, Bicky
    Jia, Xuefei
    Ahluwalia, Manmeet Singh
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (05)
  • [6] Correlation of BRAF and NRAS mutation status with tumor characteristics and treatment outcomes in melanoma patients with brain metastasis
    Koay, Eugene Jon
    Bucheit, Amanda Dawn
    Jakob, John Andrew
    Hyun, Eric D.
    Settle, Stephen H.
    Brown, Paul D.
    Davies, Michael A.
    Sulman, Erik P.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [7] BRAF and NRAS mutation status and response to checkpoint inhibition in advanced melanoma.
    van Not, Olivier Jules
    van den Eertwegh, Alfonsus Johannes Maria
    Haanen, John B. A. G.
    Blank, Christian U.
    Aarts, Maureen J. B.
    van den Berkmortel, Franchette
    de Groot, Jan Willem
    Hospers, Geke
    Kapiteijn, Ellen
    Piersma, Djura
    Van Rijn, Rozemarijn
    Stevense, Marion
    Van Der Veldt, Astrid Aplonia Maria
    Vreugdenhil, Gerard
    Boers-Sonderen, Marye
    Bonenkamp, Han J.
    Jansen, Anne M. L.
    Blokx, Willeke
    Wouters, Michel W. J. M.
    Suijkerbuijk, Karijn
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [8] Brain metastasis in melanoma patients: Associations with BRAF stains and age.
    Martinolli, Chiara
    Cocorocchio, Emilia
    Gandini, Sara
    Pennacchioli, Elisabeth
    Tosti, Giulio
    Spadola, Giuseppe
    Mosconi, Massimo
    Baldini, Federica
    Alfieri, Salvatore
    Di Leo, Maria
    Riviello, Concetta
    Barberis, Massimo
    Testori, Alessandro
    Ferrucci, Pier Francesco
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [9] Inhibition of Mutated BRAF in Melanoma.
    Kim, Taegyun
    Kim, Jihyun
    Lee, Min-Geol
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (23): : 2261 - 2261
  • [10] Hyaluronidase 1 is a vital mediator of brain metastasis in melanoma.
    O'Sullivan, Deirdre
    O'Neal, Melissa
    Felding-Habermann, Brunnhilde
    [J]. CANCER RESEARCH, 2008, 68 (09)
12345